NYSE$LEU
Centrus Energy Corp · Q2 2021 earnings
Q2 2021 earnings · · Investor relations
Briefing
Centrus reported a profitable quarter with net income, driven by technical solutions segment growth and progress in HALEU production licensing.
Centrus Energy Corp. reported a net income of $11.6 million on revenue of $62.4 million for Q2 2021. The company's consolidated cash balance was $176.0 million as of June 30, 2021. The U.S. Nuclear Regulatory Commission approved a license amendment request to produce HALEU.
- Net income was $11.6 million on $62.4 million in revenue.
- Consolidated cash balance of $176.0 million as of June 30, 2021.
- NRC approved license amendment request to produce HALEU.
- Made progress on the HALEU demonstration program, anticipating production next year.
Headline financials
Revenue & EPS history
Centrus · Revenue · Quarterly
$62.4M
Revenue by segment
Centrus · $62.4M total across 2 segments · Q2 2021
- Separative Work Units$45.2M-22.9%72.4%
- Technical Solutions$17.2M+39.8%27.6%
Forward guidance
This news release contains forward-looking statements that address matters that are, to different degrees, uncertain.
Tailwinds
- Expected future business and financial performance.
- Ability to sell LEU
- Government funding or demand for HALEU for government or commercial uses will materialize
- Ability to perform and absorb costs under our agreement with the U.S. Department of Energy (“DOE”) to demonstrate the capability to produce HALEU or obtain funding to be able to continue operations and our ability to obtain and/or perform under other agreements
- Ability to attract and retain key personnel
Headwinds
- Risks related to natural and other disasters, including the continued impact of the March 2011 earthquake and tsunami in Japan on the nuclear industry and on our business, results of operations and prospects
- Risks related to financial difficulties experienced by customers, including possible bankruptcies, insolvencies or any other inability to pay for our products or services or delays in making timely payment
- Risks related to pandemics and other health crises, such as the global COVID-19 pandemic and emerging variants
- Risks related to our ability to sell the LEU we procure pursuant to our purchase obligations under our supply agreements
- Risks related to the imposition of sanctions, restrictions or other requirements, including those imposed under the 1992 Russian Suspension Agreement (“RSA”), as amended, international trade legislation and other international trade restrictions
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2021
+0.4%
Avg return
Earnings day
+2.8%
Avg return
5 days after
+4.0%
Avg return
30 days after
48%
32 / 67 earnings
Positive
+33.1%
Q4 2024
Best reaction
-32.9%
Q3 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -10.7% | -12.9% | -30.2% | |
| Q4 2025 | -20.7% | -24.8% | -20.9% | |
| Q3 2025 | -15.1% | -15.4% | -18.3% | |
| Q1 2025 | +22.4% | +27.7% | +97.4% | |
| Q4 2024 | +33.1% | +45.1% | -2.4% | |
| Q3 2024 | +22.0% | +27.4% | -4.1% | |
| Q2 2024 | +16.0% | +9.3% | +2.1% | |
| Q1 2024 | -7.7% | -3.8% | +2.9% | |
| Q4 2023 | -4.1% | -4.7% | -15.9% | |
| Q3 2023 | -9.9% | -6.1% | -7.7% | |
| Q2 2023 | +20.9% | +23.4% | +40.5% | |
| Q1 2023 | +5.3% | +6.8% | +9.7% | |
| Q4 2022 | +13.2% | +14.9% | -26.0% | |
| Q3 2022 | -32.9% | -14.3% | -24.4% | |
| Q2 2022 | +12.0% | +16.1% | +36.7% | |
| Q1 2022 | -12.1% | -32.1% | -13.6% | |
| Q4 2021 | -20.2% | -36.3% | -38.3% | |
| Q3 2021 | +8.1% | +1.0% | -21.7% | |
| Q2 2021 | -1.9% | -7.2% | +33.1% | |
| Q1 2021 | -6.8% | -15.5% | +3.5% | |
| Q4 2020 | +8.7% | +4.5% | -14.3% | |
| Q3 2020 | +2.0% | +2.1% | +80.9% | |
| Q2 2020 | +11.6% | +5.4% | -36.1% | |
| Q1 2020 | +3.6% | +23.6% | +63.4% | |
| Q4 2019 | +16.2% | +14.7% | +31.5% | |
| Q3 2019 | +16.7% | +12.0% | -8.6% | |
| Q2 2019 | +12.8% | +0.7% | +8.2% | |
| Q1 2019 | +6.8% | +4.3% | -3.7% | |
| Q4 2018 | +2.2% | +16.5% | +17.6% | |
| Q3 2018 | -0.4% | +4.9% | -14.3% | |
| Q2 2018 | +1.7% | -2.4% | -21.9% | |
| Q1 2018 | +10.6% | +8.3% | +3.4% | |
| Q4 2017 | -2.1% | +5.4% | -8.0% | |
| Q3 2017 | -4.2% | -10.6% | -6.8% | |
| Q2 2017 | -1.9% | -0.7% | -5.3% | |
| Q1 2017 | +3.7% | -0.2% | +20.1% | |
| Q4 2016 | +2.6% | +4.5% | -7.3% | |
| Q3 2016 | -2.5% | +3.8% | +53.0% | |
| Q2 2016 | +8.7% | +12.5% | +2.4% | |
| Q1 2016 | -8.0% | — | — | |
| Q4 2015 | +28.6% | — | — | |
| Q3 2015 | -9.6% | — | — | |
| Q2 2015 | -4.8% | — | — | |
| Q1 2015 | -2.5% | — | — | |
| Q4 2014 | -1.7% | — | — | |
| Q3 2014 | +1.8% | — | — | |
| Q2 2014 | +31.4% | — | — | |
| Q4 2013 | -2.0% | — | — | |
| Q4 2012 | -2.0% | — | — | |
| Q3 2013 | -27.6% | — | — | |
| Q2 2013 | +0.8% | — | — | |
| Q1 2013 | -15.9% | — | — | |
| Q3 2012 | +0.0% | — | — | |
| Q2 2012 | -13.5% | — | — | |
| Q1 2012 | +6.6% | — | — | |
| Q4 2011 | +0.8% | — | — | |
| Q4 2008 | +0.8% | — | — | |
| Q3 2011 | -8.7% | — | — | |
| Q2 2011 | -32.7% | — | — | |
| Q1 2010 | +0.9% | — | — | |
| Q1 2011 | -1.8% | — | — | |
| Q4 2010 | +1.0% | — | — | |
| Q3 2009 | -7.2% | — | — | |
| Q3 2010 | -7.2% | — | — | |
| Q4 2009 | -3.1% | — | — | |
| Q2 2010 | -3.1% | — | — | |
| Q2 2009 | -3.1% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro